Indeed, most prostate cancer cases are dependent on androgen at initial stages, and the inhibition of the function of androgen receptors (AR) (i.e., by using anti-androgen drugs), is currently a coadjutant therapeutical approach, along with surgery or radiation, in the treatment of this type of cancer [16]. Here, AR is linked to Familial prostate cancer.